skip to main content
Show Results with:

Results 1 - 10 of 15  for Explore Further

results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Gastric Cancer, 2017, Vol.20(1), pp.182-189 [Peer Reviewed Journal]

Full text available

View all versions
2
Material Type:
Article
Add to My workspace

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

Gastric Cancer, 2014, Vol.17(2), pp.341-347 [Peer Reviewed Journal]

Full text available

View all versions
3
Material Type:
Article
Add to My workspace

A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer

Gastric Cancer, 2013, Vol.16(1), pp.41-47 [Peer Reviewed Journal]

Full text available

View all versions
4
Material Type:
Article
Add to My workspace

Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer

Gastric Cancer, 2015, Vol.18(3), pp.644-652 [Peer Reviewed Journal]

Full text available

View all versions
5
Material Type:
Article
Add to My workspace

Predictive value of CHFR and MLH1 methylation in human gastric cancer

Gastric Cancer, 2015, Vol.18(2), pp.280-287 [Peer Reviewed Journal]

Full text available

View all versions
6
Material Type:
Article
Add to My workspace

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

Gastric Cancer, Nov 2017, Vol.20(6), pp.970-977 [Peer Reviewed Journal]

No full-text

View all versions
7
Material Type:
Article
Add to My workspace

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival

Gastric Cancer, 2013, Vol.16(4), pp.581-589 [Peer Reviewed Journal]

Full text available

View all versions
8
Material Type:
Article
Add to My workspace

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Gastric Cancer, 2018, Vol.21(1), pp.84-95 [Peer Reviewed Journal]

Full text available

View all versions
9
Material Type:
Article
Add to My workspace

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

Gastric Cancer, 2014, Vol.17(4), pp.711-717 [Peer Reviewed Journal]

Full text available

View all versions
10
Material Type:
Article
Add to My workspace

Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)

Gastric Cancer, 2017, Vol.20(6), pp.1004-1009 [Peer Reviewed Journal]

Full text available

View all versions

Results 1 - 10 of 15  for Explore Further

results 1 2 next page

Searching Remote Databases, Please Wait